Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Omega 3 Supplements Market, by Functionality
1.4.2 North America Omega 3 Supplements Market, by End Use
1.4.3 North America Omega 3 Supplements Market, by Source
1.4.4 North America Omega 3 Supplements Market, by Distribution Channel
1.4.5 North America Omega 3 Supplements Market, by Form
1.4.6 North America Omega 3 Supplements Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Recent Strategies Deployed in Omega 3 Supplements Market
Chapter 5. North America Omega 3 Supplements Market by Functionality
5.1 North America Cardiovascular Health Market by Region
5.2 North America Brain, Nervous System & Mental Health Market by Region
5.3 North America Eye Diseases Market by Region
5.4 North America Diabetes Market by Region
5.5 North America Other Functionality Market by Region
Chapter 6. North America Omega 3 Supplements Market by End Use
6.1 North America Adults Market by Country
6.2 North America Geriatric Market by Country
6.3 North America Pregnant Women Market by Country
6.4 North America Children Market by Country
6.5 North America Infants Market by Country
Chapter 7. North America Omega 3 Supplements Market by Source
7.1 North America Fish Oil Market by Country
7.2 North America Algae Oil Market by Country
7.3 North America Krill Oil Market by Country
7.4 North America Other Source Market by Country
Chapter 8. North America Omega 3 Supplements Market by Distribution Channel
8.1 North America Supermarkets/ Hypermarkets/Food Stores Market by Country
8.2 North America Drug Stores & Pharmacies Market by Country
8.3 North America Online Retailers Market by Country
8.4 North America Prescribed Market by Country
8.5 North America Other Distribution Channel Market by Country
Chapter 9. North America Omega 3 Supplements Market by Form
9.1 North America Soft Gels Market by Country
9.2 North America Capsules Market by Country
9.3 North America Tablets Market by Country
9.4 North America Other Form Market by Country
Chapter 10. North America Omega 3 Supplements Market by Country
10.1 US Omega 3 Supplements Market
10.1.1 US Omega 3 Supplements Market by Functionality
10.1.2 US Omega 3 Supplements Market by End Use
10.1.3 US Omega 3 Supplements Market by Source
10.1.4 US Omega 3 Supplements Market by Distribution Channel
10.1.5 US Omega 3 Supplements Market by Form
10.2 Canada Omega 3 Supplements Market
10.2.1 Canada Omega 3 Supplements Market by Functionality
10.2.2 Canada Omega 3 Supplements Market by End Use
10.2.3 Canada Omega 3 Supplements Market by Source
10.2.4 Canada Omega 3 Supplements Market by Distribution Channel
10.2.5 Canada Omega 3 Supplements Market by Form
10.3 Mexico Omega 3 Supplements Market
10.3.1 Mexico Omega 3 Supplements Market by Functionality
10.3.2 Mexico Omega 3 Supplements Market by End Use
10.3.3 Mexico Omega 3 Supplements Market by Source
10.3.4 Mexico Omega 3 Supplements Market by Distribution Channel
10.3.5 Mexico Omega 3 Supplements Market by Form
10.4 Rest of North America Omega 3 Supplements Market
10.4.1 Rest of North America Omega 3 Supplements Market by Functionality
10.4.2 Rest of North America Omega 3 Supplements Market by End Use
10.4.3 Rest of North America Omega 3 Supplements Market by Source
10.4.4 Rest of North America Omega 3 Supplements Market by Distribution Channel
10.4.5 Rest of North America Omega 3 Supplements Market by Form
Chapter 11. Company Profiles
11.1 Nordic Naturals, Inc.
11.1.1 Company Overview
11.1.2 Recent strategies and developments:
11.1.2.1 Partnerships, Collaborations, and Agreements:
11.1.3 SWOT Analysis
11.2 Nutrigold Inc.
11.2.1 Company Overview
11.2.2 SWOT Analysis
11.3 Reckitt Benckiser Group PLC
11.3.1 Company Overview
11.3.2 Financial Analysis
11.3.3 Segmental and Regional Analysis
11.3.4 Research & Development Expenses
11.3.5 SWOT Analysis
11.4 Aker BioMarine AS
11.4.1 Company Overview
11.4.2 Financial Analysis
11.4.3 Segmental and Regional Analysis
11.4.4 Research & Development Expenses
11.4.5 Recent strategies and developments:
11.4.5.1 Product Launches and Product Expansions:
11.4.6 SWOT Analysis
11.5 NOW Foods, Inc.
11.5.1 Company Overview
11.5.2 Recent strategies and developments:
11.5.2.1 Product Launches and Product Expansions:
11.5.3 SWOT Analysis
11.6 Nature's Bounty (Nestlé Health Science S.A.) (Nestle S.A.)
11.6.1 Company Overview
11.6.2 Financial Analysis
11.6.3 Segmental and Regional Analysis
11.6.4 Research & Development Expenses
11.7 Amway Corporation
11.7.1 Company Overview
11.7.2 SWOT Analysis
11.8 New Chapter, Inc. (Procter & Gamble Inc.)
11.8.1 Company Overview
11.8.2 Financial Analysis
11.8.3 Segmental and Regional Analysis
11.8.4 Research & Development Expenses
11.8.5 Recent strategies and developments:
11.8.5.1 Product Launches and Product Expansions:
11.9 GNC Holdings, LLC (Harbin Pharmaceutical Group)
11.9.1 Company Overview
11.10. Pharmavite LLC (Otsuka Pharmaceutical Co., Ltd.)
11.10.1 Company Overview
11.10.2 Financial Analysis
11.10.3 Segmental & Regional Analysis
11.10.4 Research & Development Expense
11.10.5 SWOT Analysis
Unique Offerings 